These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2977396)

  • 21. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
    Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of carcinoembryonic antigen for monitoring tumor progression during palliative chemotherapy in metastatic colorectal cancer.
    Kim G; Jung EJ; Ryu CG; Hwang DY
    Yonsei Med J; 2013 Jan; 54(1):116-22. PubMed ID: 23225807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of carcinoembryonic antigen as a marker for colorectal liver metastases.
    Jones C; Badger SA; Epanomeratikis E; McKie LD; Diamond T; Taylor MA
    Br J Biomed Sci; 2013; 70(2):47-50. PubMed ID: 23888604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new biomarker in monitoring breast cancer: CA 549.
    Beveridge RA; Chan DW; Bruzek D; Damron D; Bray KR; Gaur PK; Ettinger DS; Rock RC; Shurbaji MS; Kuhajda FP
    J Clin Oncol; 1988 Dec; 6(12):1815-21. PubMed ID: 3058875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of preoperative computed tomography in patients with colorectal carcinoma.
    Fisher KS; Zamboni WA; Ross DS
    Am Surg; 1990 Jun; 56(6):339-42. PubMed ID: 2350106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of hepatic artery infusion therapy for hepatic metastases from colorectal carcinoma after radiological placement of infusion catheters.
    Sameshima S; Horikoshi H; Motegi K; Tomozawa S; Hirayama I; Saito T; Sawada T
    Eur J Surg Oncol; 2007 Aug; 33(6):741-5. PubMed ID: 17399936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial levels of CA 19-9 and CEA in colonic cancer.
    Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N
    J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Measurement of bile CEA levels in patients with colorectal cancer: is it of value for diagnosis of occult liver metastases aiming at prophylactic regional hepatic chemotherapy?].
    Ishida H; Hojo I; Gonda T; Nakajima H; Hirukawa H; Itoh M; Satoh K; Higuchi T; Toyooka M; Yoshinaga K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1551-4. PubMed ID: 8373216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of CEA level determination in gallbladder bile in the diagnosis of liver metastases secondary to colorectal adenocarcinoma.
    Moura RM; Matos D; Galvão Filho MM; D'Ippólito G; Sjzenfeld J; Giuliano LM
    Sao Paulo Med J; 2001 May; 119(3):110-3. PubMed ID: 11391453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC).
    Tsavaris N; Vonorta K; Tsoutsos H; Kozatsani-Halividi D; Mylonakis N; Papagrigoriou D; Koutsiouba-Kazakou P; Kosmidis P
    Int J Biol Markers; 1993; 8(2):88-93. PubMed ID: 7690061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.
    van Kamp GJ; von Mensdorff-Pouilly S; Kenemans P; Verstraeten R; Yedema CA; Wobbes T; Bon GG; Kok A; Brown JP; Hilgers J
    Clin Chem; 1993 Jun; 39(6):1029-32. PubMed ID: 8504532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    J Gastrointest Surg; 2001; 5(3):294-302. PubMed ID: 11360053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer.
    Nagai Y; Beppu T; Sakamoto Y; Miyamoto Y; Hayashi H; Nitta H; Imai K; Masuda T; Okabe H; Hirashima K; Imamura Y; Baba Y; Chikamoto A; Baba H
    Anticancer Res; 2014 Oct; 34(10):5529-35. PubMed ID: 25275051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
    Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.